PAVmed (PAVM) Shareholder's Equity Growth (3y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26.82% |
| Sep 30, 2025 | 4.43% |
| Jun 30, 2025 | -12.06% |
| Mar 31, 2025 | -15.59% |
| Dec 31, 2024 | -26.65% |
| Jun 30, 2024 | -34.69% |
| Mar 31, 2024 | -34.41% |
| Dec 31, 2023 | -270.30% |
| Sep 30, 2023 | -2.35% |
| Jun 30, 2023 | 59.83% |
| Mar 31, 2023 | 38.66% |
| Dec 31, 2022 | 63.33% |
| Sep 30, 2022 | 140.23% |
| Jun 30, 2022 | 188.59% |
| Mar 31, 2022 | 137.64% |
| Dec 31, 2021 | 224.20% |
| Sep 30, 2021 | 114.63% |
| Jun 30, 2021 | 86.11% |
| Mar 31, 2021 | 478.73% |
| Dec 31, 2020 | 45.03% |
| Sep 30, 2020 | -35.65% |
| Jun 30, 2020 | -36.36% |
| Mar 31, 2020 | -55.52% |
| Dec 31, 2019 | -144.05% |
| Sep 30, 2019 | -60.11% |
| Jun 30, 2019 | -38.96% |
| Dec 31, 2018 | -80.76% |